151 related articles for article (PubMed ID: 9545022)
1. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
[TBL] [Abstract][Full Text] [Related]
2. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
4. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
[TBL] [Abstract][Full Text] [Related]
5. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
Hayes MR; Bradley L; Grill HJ
Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
[TBL] [Abstract][Full Text] [Related]
6. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
Rinaman L
Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
8. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.
Donahey JC; van Dijk G; Woods SC; Seeley RJ
Brain Res; 1998 Jan; 779(1-2):75-83. PubMed ID: 9473596
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.
Hwa JJ; Ghibaudi L; Williams P; Witten MB; Tedesco R; Strader CD
Peptides; 1998; 19(5):869-75. PubMed ID: 9663452
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats.
Rinaman L; Rothe EE
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R99-106. PubMed ID: 12069935
[TBL] [Abstract][Full Text] [Related]
12. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
[TBL] [Abstract][Full Text] [Related]
13. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
Kinzig KP; D'Alessio DA; Seeley RJ
J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the brainstem preproglucagon system in the obese Zucker rat.
Vrang N; Larsen PJ; Jensen PB; Lykkegaard K; Artmann A; Larsen LK; Tang-Christensen M
Brain Res; 2008 Jan; 1187():116-24. PubMed ID: 18022140
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
Wang T; Edwards GL; Baile CA
Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.
Blázquez E; Alvarez E; Navarro M; Roncero I; Rodríguez-Fonseca F; Chowen JA; Zueco JA
Mol Neurobiol; 1998 Oct; 18(2):157-73. PubMed ID: 10065878
[TBL] [Abstract][Full Text] [Related]
19. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.
Lankat-Buttgereit B; Göke R; Stöckmann F; Jiang J; Fehmann HC; Göke B
Digestion; 1994; 55(1):29-33. PubMed ID: 8112494
[TBL] [Abstract][Full Text] [Related]
20. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
